期刊文献+

利拉鲁肽对肥胖大鼠脂肪组织内质网应激的影响 被引量:3

Effects of Liraglutide on Endoplasmic Reticulum Stress of Fatty Tissue in Obese Rats
原文传递
导出
摘要 目的:研究利拉鲁肽对肥胖大鼠脂肪组织内质网应激的影响。方法:取大鼠分别用基础饲料和高脂饲料喂养8周后,分为正常对照组、肥胖组、肥胖-利拉鲁肽组,前2组大鼠腹腔注射0.9%氯化钠注射液,肥胖-利拉鲁肽组大鼠腹腔注射利拉鲁肽100μg/kg,每日2次,连续8周。末次给药后隔夜禁食处死大鼠,称体质量,取肾周及睾周脂肪组织,计算脂体比,检测脂肪组织中类蛋白质激酶激活的双链RNA的内质网激酶(PERK)、肌醇需求激酶1-α(IRE1-α)、C/EBP同源蛋白(CHOP)mRNA的表达和葡萄糖转运蛋白78(GRP78)的表达。结果:与正常对照组比较,肥胖组大鼠体质量、脂体比和脂肪组织中PERK、IRE1-α、CHOP mRNA及GRP78蛋白表达均明显升高(P<0.01);与肥胖组比较,肥胖-利拉鲁肽组大鼠上述指标均明显降低(P<0.01)。结论:利拉鲁肽可显著减轻肥胖大鼠体质量及内脏脂肪组织过度累积,并可缓解脂肪组织内质网应激。 OBJECTIVE:To study the effects of liraglutide on endoplasmic reticulum stress of fatty tissue in obese rats.METHODS:48 rats were divided into normal control group,obesity group and obesity-liraglutide group after given basal feed and high-fat diet for 8 weeks.The first 2 groups were given 0.9% Sodium chloride injection intraperitoneally,and obesity-liraglutide group was given intraperitoneal injection of liraglutide 100 μg/kg twice a day for consecutive 8 weeks.All rats were fasting overnight and sacrificed after last administration.Each rat of three groups was weighted,and the fatty tissue around kidney and epididymis were removed to calculate lipid ratio.The expressions of PERK,IRE1-α,CHOP mRNA and GRP78 protein in fatty tissue were measured.RESULTS:Compared with normal control group,the body weight,lipid ratio and the expressions of PERK,IRE1-α,CHOP mRNA and GRP78 protein in fatty tissue of obesity group were increased significantly(P〈0.01);compared with obesity group,the above index of obesity-liraglutide group were decreased significantly(P〈0.01).CONCLUSIONS:Liraglutide may ameliorate the body weight gain in obese rats and excessive accumulation of visceral adipose tissue,and significantly relieve endoplasmic reticulum stress in the fatty tissue.
出处 《中国药房》 CAS CSCD 2014年第21期1946-1948,共3页 China Pharmacy
关键词 肥胖 大鼠 利拉鲁肽 内质网应激 Obesity Rats Liraglutide Endoplasmic reticulum stress
  • 相关文献

参考文献18

  • 1MedaniD,Pucarin-CvetkoviJ.Obesity-a public health problem and challenge[J].Acta Med Croatica,2012,66(5):347.
  • 2李敬华,张红,候雯莉.肠促胰岛素生理作用及应用研究进展[J].武警医学院学报,2011,20(7):597-599. 被引量:10
  • 3Cunha DA,Ladriere L,Ortis F,et al.GLP-1 agonists protect pancreaticβ-cells from lipotoxic endoplasmic reticulum stress through upregulation of BiP and JunB[J].Diabetes,2009,58(12):2 851.
  • 4Chen J,Guo H,Zheng G,et al.Region-specific vulnerability to endoplasmic reticulum stress-induced neuronal death in rat brain after status epilepticus[J].J Biosci,2013,38(5):877.
  • 5Teodoro-Morrison T,Schuiki I,Zhang L,et al.GRP78overproduction in pancreatic beta cells protects against high-fat-diet-induced diabetes in mice[J].Diabetologia,2013,56(5):1 057.
  • 6Liu J,Liu Y,Chen L,et al.Glucagon-like peptide-1 analog liraglutide protects against diabetic cardiomyopathy by the inhibition of the endoplasmic reticulum stress pathway[J].J Diabetes Res,2013:630 537.
  • 7Lee J,Ozcan U.Unfolded protein response signaling and metabolic diseases[J].J Biol Chem,2014,289(3):1 203.
  • 8Han J,Murthy R,Wood B,et al.ER stress signalling through eIF2αand CHOP,but not IRE1α,attenuates adipogenesis in mice[J].Diabetologia,2013,56(4):911.
  • 9Chen YQ,Chen MJ,Wu ZH,et al.Ox-LDL induces ER stress and promotes the adipokines secretion in 3T3-L1 adipocytes[J].PLoS One,2013,8(10):e81 379.
  • 10Engin F,Nguyen T,Yermalovich A,et al.Aberrant islet unfolded protein response in type 2 diabetes[J].Scientific Reports,2014:4 054.

二级参考文献20

  • 1杨立业,黄天华.GLP-1(1~37)诱导人类胚胎小肠上皮细胞表达胰岛素[J].生物化学与生物物理进展,2005,32(6):576-580. 被引量:2
  • 2王璐,邸阜生.肠促胰岛素类似物和DPP-Ⅳ抑制剂在2型糖尿病治疗中的作用[J].医学综述,2007,13(1):25-27. 被引量:6
  • 3高虹,宁光.胰高血糖素样肽1的胰腺外作用研究进展[J].国际内科学杂志,2007,34(7):408-411. 被引量:25
  • 4Pratley RE,Matfin G.Pre-diabetes:clinical relevance and therapeutic approach[J].Diabetes Vasc Dis,2007,7(6):120-129.
  • 5Nauck M.Glucgon-like peptide-1 in type 2 diabetes:the B cell and beyond[J].Diabetes Obes Metab,2008,10(2):2-13.
  • 6Unger RH,Eisentraut AM.Entero-insular axis[J].Archs Intern Med,1969,123(3):261-266.
  • 7Hoist JJ.The physiology of glucagon-like peptide-1[J].Physiol Rev,2007,87(4):1409-1439.
  • 8Suzuki A,Nakauchi H,Taniguchi H.Glucagon-like peptide 1(1-37) converts intestinal epithelial cells into insulinproducing cells[J].Proc Nat Acad Sci,2003,100(4):5034-5039.
  • 9Meier JJ,Gallwitz B,Wolfgang E,et al.Glucagon-like peptide 1 as a regulator of food intake and body weight:therapeutic perspectives[J].Eur J Pharmacol,2002,440(8):269-279.
  • 10Kendall DM,Riddle MC,Rosenstock J,et al.Effects of exenatide(exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea[J].Diabetes Care,2005,28(5):1083-1091.

共引文献9

同被引文献9

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部